CompletedPhase 3

A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)

United States376 participantsStarted 2024-09-13

Plain-language summary

The main purpose of this study is to evaluate the efficacy and safety of orforglipron on maintenance of body weight reduction.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Have completed the SURMOUNT-5 study on study treatment Exclusion Criteria: * Have Type 1 Diabetes, Type 2 Diabetes, or any other types of diabetes, history of ketoacidosis, or hyperosmolar state/coma * Have a prior or planned surgical treatment for obesity * Have acute or chronic hepatitis * Have a history of acute or chronic pancreatitis

What they're measuring

Percent Maintenance of Body Weight Reduction Achieved in SURMOUNT-5

Timeframe: Week 52

Trial details

NCT IDNCT06584916

SponsorEli Lilly and Company

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-11-21

View on ClinicalTrials.gov More Obesity trials